Functional Analysis of Phosphorylation at Serine 532 of Human c-Myb by MAP Kinase
- 1 January 1996
- journal article
- Published by Walter de Gruyter GmbH in Biological Chemistry Hoppe-Seyler
- Vol. 377 (11) , 721-730
- https://doi.org/10.1515/bchm3.1996.377.11.721
Abstract
The c-myb proto-oncogene encodes a transcription factor that is implicated in regulatory events during hematopoiesis. It contains negative regulatory domains at both the amino- and carboxy-termini. Here we describe that human c-Myb can be phosphorylated by mitogen-activated protein kinases (MAPK's) at serine 532 of the carboxy (C-) terminal regulatory domain in vitro. This serine residue can also be phosphorylated in vivo upon serum-stimulation of Jurkat cells. Expression of a constitutively active form of Ras together with c-Myb in transient transfection experiments had no effect on the transcriptional activity of c-Myb, while expression of a polypeptide containing the c-Myb C-terminal domain stimulated c-Myb activity. This effect is reduced upon MAPK-dependent phosphorylation of serine 532. Our data suggest that the MAPK-dependent state of phosphorylation modifies the cellular function of c-Myb by modulating its interaction with a putative inhibitory factor.Keywords
This publication has 27 references indexed in Scilit:
- CBP as a transcriptional coactivator of c-Myb.Genes & Development, 1996
- Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activationCell, 1995
- Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helicesCell, 1994
- Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb.The Journal of cell biology, 1992
- Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activationNature, 1990
- The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 geneCell, 1989
- Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-mybCell, 1989
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemiaNature, 1984